Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill tested to control dangerous low platelet disorder

NCT ID NCT07007962

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study is testing an oral medication called rilzabrutinib for adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing bleeding risk. It's for people whose first treatment didn't work well or stopped working. The main goal is to see if the drug can safely and effectively raise and maintain platelet counts over time to reduce bleeding.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Community Cancer Trials of Utah_Investigational Site Number: 8400002

    RECRUITING

    Ogden, Utah, 84405, United States

  • Investigational Site Number : 2500001

    RECRUITING

    Dijon, 21079, France

  • Investigational Site Number : 2500002

    RECRUITING

    Pessac, 33604, France

  • Investigational Site Number : 2500004

    RECRUITING

    Toulouse, 31059, France

  • Investigational Site Number : 3480002

    RECRUITING

    Kaposvár, 7400, Hungary

  • Investigational Site Number : 6160003

    RECRUITING

    Skorzewo, 60-185, Poland

  • Investigational Site Number : 6160004

    RECRUITING

    Słupsk, 76-200, Poland

  • Investigational Site Number: 2500003

    RECRUITING

    Créteil, 94000, France

  • Mayo Clinic_Investigational Site Number: 8400009

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • New York Oncology Hematology_Investigational Site Number: 8400010

    RECRUITING

    Albany, New York, 12208, United States

Conditions

Explore the condition pages connected to this study.

IMMUNE THROMBOCYTOPENIA